For cystic fibrosis (CF) patients, the benefits of elexacaftor-tezacaftor-ivacaftor (ETI; Trikafta) may extend to relief from chronic rhinosinusitis, a small cohort study suggested. After a year of ...

Please provide your email address to receive an email when new articles are posted on . Patients with cystic fibrosis had improved chronic rhinosinusitis outcomes ...

Please provide your email address to receive an email when new articles are posted on . From infancy to preschool age, average chronic rhinosinusitis MRI score went up, signaling more severe sinus ...

Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...